Oral vs. Infusion Medications for Parkinson’s Disease: What You Need to Know

Medically reviewed by Nancy Hammond, M.D. - Written by Hope Gillette on January 20, 2026

Key takeaways

• Oral medications are often the first treatment for Parkinson’s disease. They work by increasing dopamine levels or mimicking dopamine’s effects, but symptom control may change over time.
• Infusion therapies deliver medication continuously, which can reduce symptom fluctuations and offer more consistent control, especially in later stages of Parkinson’s.
• Choosing a treatment depends on symptoms, disease progression, treatment response, daily routines, and personal preferences. Talking through all options with your healthcare team can help guide the decision.

Parkinson’s disease is a progressive condition that affects how the brain controls movement. It develops when changes in the brain disrupt the nerve cells that help coordinate motion.

As the condition progresses, damage to these nerve cells can lead to symptoms such as tremors, muscle stiffness, slowed movement, and changes in balance or coordination. Symptoms often evolve over time, which can affect how well different treatments work.

Medications play a central role in managing Parkinson’s symptoms. These treatments may be taken by mouth or delivered via infusion. The best option depends on a person’s symptoms, how their body responds to treatment, and how treatment fits into their daily life.

Oral medications for Parkinson’s disease

Oral medications are those you take by mouth. In Parkinson’s disease, many oral medications fall under what’s known as “dopaminergic therapy,” which is often the first treatment approach. These medications work by replacing dopamine or mimicking its effects in the brain.

Parkinson’s disease affects cells that produce dopamine, a chemical that helps coordinate movement. When dopamine levels drop, the brain has a harder time sending clear signals to the muscles. This can lead to symptoms such as stiffness, slowed movement, tremors, or difficulty with coordination.

While dopaminergic therapy is a mainstay of Parkinson’s treatment, not all oral medications work the same way.

Some target other brain chemicals (neurotransmitters) involved in movement or non-motor symptoms, offering additional options when dopamine-based treatments alone aren’t enough.